Anti-SARS-CoV-2 Action of 5α-Reductase Inhibitors May Be Mediated by Dehydroepiandrosterone. Letter

J Urol. 2022 May;207(5):1163-1164. doi: 10.1097/JU.0000000000002469. Epub 2022 Feb 4.

Authors

Konstantinos I Papadopoulos¹, Alexandra Papadopoulou², Warachaya Sutheesophon¹, Tar-Choon Aw³

Affiliations

¹ THAI StemLife, Wangthonglang, Bangkok, Thailand.
² Occupational and Environmental Health, City of Lund, Lund, Sweden.
³ Department of Laboratory Medicine, Changi General Hospital, Singapore, Singapore.

PMID: 35119308
DOI: 10.1097/JU.0000000000002469

No abstract available

Publication types

Letter
Comment

MeSH terms

3-Oxo-5-alpha-Steroid 4-Dehydrogenase
5-alpha Reductase Inhibitors* / pharmacology
5-alpha Reductase Inhibitors* / therapeutic use
COVID-19*
Dehydroepiandrosterone / pharmacology
Enzyme Inhibitors / pharmacology
Humans
Oxidoreductases
SARS-CoV-2

Substances

5-alpha Reductase Inhibitors
Enzyme Inhibitors
Dehydroepiandrosterone
Oxidoreductases
3-Oxo-5-alpha-Steroid 4-Dehydrogenase